Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Biden’s clean energy agenda faces mounting headwinds
Post Content Post Views: 113
Citigroup stresses vigilance after sexual misconduct suit
Post Content Post Views: 139
Urban Outfitters down 7% despite quarterly beats
Post Content Post Views: 135
Argentina’s Milei seeks foreign policy, IMF reset in Washington trip
Post Content Post Views: 121
Spain and Brazil leaders to discuss EU-Mercosur deal at COP – sources
Post Content Post Views: 124
Phoenix Motor secures contract by Florida Sheriffs Association program
Post Content Post Views: 132